Literature DB >> 12766616

Laser capture microdissection and real-time PCR for analysis of glomerular endothelin-1 gene expression in mesangiolysis of rat anti-Thy 1.1 and murine Habu Snake Venom glomerulonephritis.

A Dimmler1, C S Haas, S Cho, M Hattler, C Forster, H Peters, H O Schöcklmann, K Amann.   

Abstract

Molecular analysis of pathologic changes in glomeruli requires methods allowing rapid and exact detection of alterations in gene expression. Here, we analyzed endothelin-1 (ET-1) mRNA expression in mesangiolytic glomeruli during the course of a rat and murine model of mesangioproliferative glomerulonephritis (GN). A novel method combining laser capture microdissection (LCM), which permits the precise removal of selected mesangiolytic glomeruli, with a highly sensitive real-time RT-PCR technique was used. Anti-Thy 1.1. GN was introduced in male Sprague-Dawley rats (1.0 mg/kg body weight of OX-7 IV) and Habu Snake Venom GN was introduced in C57BL6 mice (habu snake venom toxin 6 mg/kg body weight IV). The degree of mesangiolysis during both GNs was analyzed using a semiquantitative scoring system. Mesangiolytic glomeruli were microdissected at different days of the diseases (day 2, 6, and 12 in anti-Thy 1.1 GN and days 1, 3, 7, and 14 in Habu Snake Venom GN) and from normal control animals. After RNA extraction and cDNA synthesis, ET-1 gene expression was measured by real-time RT-PCR. In parallel, in anti-Thy 1.1. GN ET-1 mRNA expression was analyzed using semiquantitative nonradioactive in situ hybridization; ET-1 protein expression was investigated by immunohistochemistry. Mesangiolysis peaked at day 6 in anti-Thy1.1 GN and at day 1 in Habu Snake Venom GN. Mesangiolytic glomeruli were easily microdissected on cryostat sections in both models; quantification of mRNA with RT-PCR was reliable and reproducible. Glomerular ET-1 mRNA expression increased during the course of anti-Thy 1.1 GN and Habu Snake Venom GN peaked when mesangiolysis was most pronounced. This was seen by RT-PCR after glomerular LCM and by in situ hybridization; in parallel, glomerular ET-1 protein expression was increased. Combination of LCM and RT-PCR is a reliable method for quantification of localized gene expression in isolated renal structures. The above data argue for an important role of ET-1 in pathogenesis and/or repair of mesangiolysis in experimental mesangioproliferative GN.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766616     DOI: 10.1097/00019606-200306000-00007

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  5 in total

1.  Laser-assisted microdissection of the kidney: fundamentals and applications.

Authors:  Gregory L Blakey; Zoltan G Laszik
Journal:  J Mol Histol       Date:  2004-08       Impact factor: 2.611

2.  Cell cycle re-entry sensitizes podocytes to injury induced death.

Authors:  Manuel Hagen; Eva Pfister; Andrea Kosel; Stuart Shankland; Jeffrey Pippin; Kerstin Amann; Christoph Daniel
Journal:  Cell Cycle       Date:  2016-05-27       Impact factor: 4.534

3.  Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis.

Authors:  Christian S Haas; Valentina Câmpean; Alexander Kuhlmann; Arno Dimmler; Udo Reulbach; Christian Forster; Thomas Aigner; Till Acker; Karl Plate; Kerstin Amann
Journal:  Virchows Arch       Date:  2006-11-22       Impact factor: 4.064

4.  Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.

Authors:  Oliver Jung; Felix Jansen; Anja Mieth; Eduardo Barbosa-Sicard; Rainer U Pliquett; Andrea Babelova; Christophe Morisseau; Sung H Hwang; Cindy Tsai; Bruce D Hammock; Liliana Schaefer; Gerd Geisslinger; Kerstin Amann; Ralf P Brandes
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

5.  Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy.

Authors:  Christoph Daniel; Regina Vogelbacher; Andrea Stief; Christina Grigo; Christian Hugo
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.